Psilocybin is the major psychoactive compound present in magic mushrooms. Much like cannabis, psilocybin is classified as a Schedule 1 controlled substance with no medical purpose. However, recent studies have identified important medical effects of psilocybin. One area where psilocybin has been purported to affect is in the treatment of depression. The beneficial compound has been approved on two occasions for trials regarding depression by the FDA. The first trial for the compound was for severe treatment-resistant depression. The second approval was directed towards major depressive disorder. Major depressive disorder is a very common condition with over 300 million suffering from the condition.
For our 50th anniversary, we handed the plant to the artists making its most striking…
Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…
By gently heating your plant matter instead of setting it on fire, a vaporizer extracts…
For the past five years, Texas has lived in a strange legal limbo. The 2018…
Thirty years after Prop 215, the California State Fair crowned its first home-grow champion and…
Senate leaders released a stopgap that would push most of the federal hemp deadline to…